Let’s Talk Business is the Argus Leader’s regular snippet of news about the latest openings, expansions or closings across ...
Hundreds of thousands of Amazon packages travel through the Nashville area each day. Here's the work and planning behind ...
The AI market cap race among the biggest tech giants reveals a brutal reshuffling of power, and one social media behemoth is watching its AI ambitions get priced into irrelevance while a private ...
AMZN burned -$8.8B in free cash flow last quarter, but META's slim $784M surplus masks deeper structural risk with no cloud revenue to recoup hardware costs. AWS hit a 39% margin with a $496B backlog, ...
For the past year or so, booksellers have suspected that AI firms are buying up huge lots of rare books, then destroying them after scanning them to train AI. But this was hard to prove until now, as ...
New York City Mayor Zohran Mamdani recently announced his support for the Delivery Protection Act that is pending before the City Council. The act would require companies that use gig delivery workers ...
Delays one after another have frustrated the progress of Amazon Leo, a long-planned internet service that requires putting thousands of satellites 370 miles overhead. Amazon founder Jeff Bezos was ...
New York Mayor Zohran Mamdani appears in a video supporting the Delivery Protection Act, which would protect delivery drivers in the city. Credit: Screenshot/NYC Mayor's Office Amazon’s chief lobbyist ...
Morgan Stanley maintained its positive rating on Silence Therapeutics (SLN) after Phase 2 results for the biotechnology company’s divesiran showed what analysts described as potential “best-in-class” ...
Hosted on MSN
Amazon just joined the $3 trillion club. Here's why it could reach $5 trillion by 2029.
Amazon topped a $3 trillion market valuation on the back of strong earnings results. It's spending huge amounts to build more data centers and drive cloud computing revenue growth. A few issues could ...
Silence Therapeutics (SLN) shares surged as much as 41% to a 52-week high Monday after the clinical-stage biotechnology company reported quarterly results alongside positive Phase 2 data for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results